# NUFYMCO
> **BLA761473** · Biologics License Application · Sponsor: FORMYCON AG · Approved 2025-12-18
## Drug
- **FDA Application Number:** BLA761473
- **Application type:** Biologics License Application
- **Brand name:** NUFYMCO
- **Generic name:** Ranibizumab-Leyk
- **Active ingredients:** RANIBIZUMAB-LEYK
- **Dosage form:** INJECTION
- **Route:** —
- **Marketing status:** Prescription
- **Sponsor:** FORMYCON AG
- **First approval:** 2025-12-18
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761473)
---
*AI Analytics · CC0 1.0*